OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

OPTUS Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	37,485	26,906	17,811	10,409	32,555	42,423
Short-Term Investments	7,000	24,000	40,000	40,000	42,000	39,973
Trading Asset Securities	1,986	502.41	10,711	11,146	-	-
Cash & Short-Term Investments	46,471	51,408	68,522	61,555	74,555	82,395
Cash Growth	-31.31%	-24.98%	11.32%	-17.44%	-9.52%	19.14%
Accounts Receivable	10,711	13,492	9,321	7,472	6,313	3,875
Other Receivables	891.83	231.04	632.99	418.49	223.12	208.61
Receivables	11,625	13,753	9,995	7,908	6,564	4,108
Inventory	16,150	12,500	13,071	11,622	9,791	6,748
Prepaid Expenses	253.04	172.83	137.33	83.78	105.4	65.87
Other Current Assets	371.43	61.71	46.08	217.78	1	113.44
Total Current Assets	74,870	77,896	91,772	81,386	91,017	93,431
Property, Plant & Equipment	67,873	56,863	42,501	43,735	38,717	28,267
Long-Term Investments	11,819	13,740	13,497	10,121	9,636	8,127
Other Intangible Assets	15,868	16,066	-	-	-	-
Long-Term Accounts Receivable	-	-	-	-	-0	-0
Long-Term Deferred Tax Assets	-	-	-	-	614.46	-
Other Long-Term Assets	1,349	1,928	1,647	963.78	53.31	71.77
Total Assets	171,786	166,503	149,460	136,240	140,038	129,897
Accounts Payable	2,692	3,124	1,889	1,536	1,519	1,213
Accrued Expenses	7,127	5,638	7,976	5,804	4,885	3,908
Current Portion of Leases	703.68	694.79	713.48	680.29	73.11	108.03
Current Income Taxes Payable	689.46	423.89	1,147	289.1	1,197	1,283
Other Current Liabilities	11,804	11,229	1,347	1,450	3,701	2,070
Total Current Liabilities	23,016	21,110	13,072	9,760	11,375	8,582
Long-Term Leases	593.21	758.87	1,359	1,918	167.1	352.32
Long-Term Deferred Tax Liabilities	730.17	738.22	494.15	14.92	-	828.05
Other Long-Term Liabilities	170.06	161.73	83.75	79.51	0	-
Total Liabilities	24,509	22,768	15,009	11,773	13,018	11,014
Common Stock	8,282	8,282	8,282	8,282	8,282	8,282
Additional Paid-In Capital	36,613	36,601	36,553	36,663	36,663	36,663
Retained Earnings	107,929	103,978	95,689	86,636	85,281	77,034
Treasury Stock	-5,522	-5,580	-5,751	-6,352	-3,068	-3,068
Comprehensive Income & Other	-26.31	453.44	-322.28	-762.48	-137.35	-28.86
Shareholders' Equity	147,277	143,735	134,451	124,467	127,021	118,883
Total Liabilities & Equity	171,786	166,503	149,460	136,240	140,038	129,897
Total Debt	1,297	1,454	2,073	2,598	240.2	460.35
Net Cash (Debt)	45,174	49,955	66,450	58,956	74,315	81,935
Net Cash Growth	-31.39%	-24.82%	12.71%	-20.67%	-9.30%	18.78%
Net Cash Per Share	2956.45	3271.01	4372.19	3717.14	4635.53	5079.34
Filing Date Shares Outstanding	15.29	15.29	15.26	15.17	16.04	16.04
Total Common Shares Outstanding	15.29	15.29	15.26	15.17	16.04	16.04
Working Capital	51,854	56,787	78,700	71,626	79,642	84,849
Book Value Per Share	9629.14	9403.11	8811.11	8207.04	7918.38	7411.07
Tangible Book Value	131,409	127,669	134,451	124,467	127,021	118,883
Tangible Book Value Per Share	8591.70	8352.11	8811.11	8207.04	7918.38	7411.07
Land	5,271	5,271	5,271	5,478	5,584	5,584
Buildings	18,945	19,266	19,188	19,938	16,130	13,534
Machinery	11,092	12,099	13,415	14,420	4,577	5,406
Construction In Progress	31,044	18,412	1,999	506.56	12,183	3,291

Source: S&P Global Market Intelligence. Standard template. Financial Sources.